PortfoliosLab logoPortfoliosLab logo
ASTI vs. VNDA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ASTI vs. VNDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ascent Solar Technologies Inc. (ASTI) and Vanda Pharmaceuticals Inc. (VNDA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ASTI achieves a 41.36% return, which is significantly higher than VNDA's -31.97% return. Over the past 10 years, ASTI has underperformed VNDA with an annualized return of -75.27%, while VNDA has yielded a comparatively higher -6.02% annualized return.


ASTI

1D
-6.59%
1M
8.40%
YTD
41.36%
6M
49.74%
1Y
270.06%
3Y*
-86.46%
5Y*
-91.83%
10Y*
-75.27%

VNDA

1D
3.45%
1M
-3.07%
YTD
-31.97%
6M
-14.65%
1Y
33.04%
3Y*
-2.73%
5Y*
-20.51%
10Y*
-6.02%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ASTI vs. VNDA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ASTI
Ascent Solar Technologies Inc.
41.36%25.69%-96.24%-99.73%-86.96%-68.75%7,900.00%-99.32%1,544.44%-68.97%
VNDA
Vanda Pharmaceuticals Inc.
-31.97%84.13%13.51%-42.90%-52.90%19.41%-19.93%-37.20%71.91%-4.70%

Correlation

The correlation between ASTI and VNDA is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.08

Correlation (10Y)
Calculated over the trailing 10-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Jul 25, 2006

0.09

The correlation between ASTI and VNDA shifts across timeframes, from 0.05 (10 years) to 0.17 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ASTI:

$46.30M

VNDA:

$356.76M

EPS

ASTI:

-$2.15

VNDA:

-$4.05

PS Ratio

ASTI:

198.96

VNDA:

1.63

PB Ratio

ASTI:

2.76

VNDA:

1.27

Total Revenue (TTM)

ASTI:

$113.09K

VNDA:

$217.78M

Gross Profit (TTM)

ASTI:

-$757.46K

VNDA:

$154.79M

EBITDA (TTM)

ASTI:

-$7.98M

VNDA:

-$146.81M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASTI vs. VNDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASTI
ASTI Risk / Return Rank: 8686
Overall Rank
ASTI Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
ASTI Sortino Ratio Rank: 9191
Sortino Ratio Rank
ASTI Omega Ratio Rank: 8888
Omega Ratio Rank
ASTI Calmar Ratio Rank: 9090
Calmar Ratio Rank
ASTI Martin Ratio Rank: 8383
Martin Ratio Rank

VNDA
VNDA Risk / Return Rank: 6060
Overall Rank
VNDA Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
VNDA Sortino Ratio Rank: 6161
Sortino Ratio Rank
VNDA Omega Ratio Rank: 6363
Omega Ratio Rank
VNDA Calmar Ratio Rank: 6060
Calmar Ratio Rank
VNDA Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASTI vs. VNDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ascent Solar Technologies Inc. (ASTI) and Vanda Pharmaceuticals Inc. (VNDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ASTIVNDADifference
Sharpe ratioReturn per unit of total volatility

+0.81

Sortino ratioReturn per unit of downside risk

+2.02

Omega ratioGain probability vs. loss probability

1.39

1.18

+0.22

Calmar ratioReturn relative to maximum drawdown

4.38

0.83

+3.55

Martin ratioReturn relative to average drawdown

7.38

1.79

+5.59

ASTI vs. VNDA - Sharpe Ratio Comparison

The current ASTI Sharpe Ratio is 1.22, which is higher than the VNDA Sharpe Ratio of 0.41. The chart below compares the historical Sharpe Ratios of ASTI and VNDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ASTI vs. VNDA - Drawdown Comparison

The maximum ASTI drawdown since its inception was -100.00%, roughly equal to the maximum VNDA drawdown of -98.42%. Use the drawdown chart below to compare losses from any high point for ASTI and VNDA.


Loading charts...

Drawdown Indicators


ASTIVNDADifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-98.42%

-1.58%

Max Drawdown (1Y)

Largest decline over 1 year

-62.08%

-40.06%

-22.02%

Max Drawdown (3Y)

Largest decline over 3 years

-99.96%

-49.25%

-50.71%

Max Drawdown (5Y)

Largest decline over 5 years

-100.00%

-84.29%

-15.71%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

-89.26%

-10.74%

Current Drawdown

Current decline from peak

-100.00%

-81.05%

-18.95%

Average Drawdown

Average peak-to-trough decline

-90.37%

-65.11%

-25.26%

Ulcer Index

Depth and duration of drawdowns from previous peaks

36.77%

18.50%

+18.27%

Volatility

ASTI vs. VNDA - Volatility Comparison

Ascent Solar Technologies Inc. (ASTI) has a higher volatility of 59.59% compared to Vanda Pharmaceuticals Inc. (VNDA) at 11.99%. This indicates that ASTI's price experiences larger fluctuations and is considered to be riskier than VNDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ASTIVNDADifference

Volatility (1M)

Calculated over the trailing 1-month period

59.59%

11.99%

+47.60%

Volatility (6M)

Calculated over the trailing 6-month period

136.12%

64.42%

+71.70%

Volatility (1Y)

Calculated over the trailing 1-year period

223.63%

81.84%

+141.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

162.79%

60.53%

+102.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

8,956.71%

55.71%

+8,901.00%

Dividends

ASTI vs. VNDA - Dividend Comparison

Neither ASTI nor VNDA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ASTI vs. VNDA - Financials Comparison

This section allows you to compare key financial metrics between Ascent Solar Technologies Inc. and Vanda Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M20222023202420252026
51.94K
51.72M
(ASTI) Total Revenue
(VNDA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ASTI and VNDA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASTI has higher volatility (59.59%) compared to VNDA (11.99%). In terms of maximum drawdown, ASTI dropped -100.00% vs VNDA's -98.42%.

ASTI currently has the higher Sharpe Ratio (1.22 vs 0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ASTI and VNDA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer